Referências

1. Atlanta CR, 2018, CLIFTON ROAD ATLANTA
2. Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
3. Coelho FF, 2014, ABCD-ARQ BRAS CIR DI, V27, P138, DOI 10.1590/S0102-67202014000200011
4. Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531
5. Darre T, 2019, PATHOL ONCOL RES
6. Gaye AM, 2016, B CANCER, V103, P806, DOI 10.1016/j.bulcan.2016.07.002
7. Gryseels B, 2012, INFECT DIS CLIN N AM, V26, P383, DOI 10.1016/j.idc.2012.03.004
8. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P1
9. Isaji S, 2018, PANCREATOLOGY, V18, P2, DOI 10.1016/j.pan.2017.11.011
10. ISTRE GR, 1984, JAMA-J AM MED ASSOC, V251, P508, DOI 10.1001/jama.251.4.508
11. Japanese Gastric Canc Assoc, 2017, GASTRIC CANCER, V20, P1, DOI 10.1007/s10120-016-0622-4
12. LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31
13. Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187
14. Ramos Marcus Fernando Kodama Pertille, 2018, Clinics, V73, pe543s, DOI 10.6061/clinics/2018/e543s
15. Ryan ET, 2007, NEW ENGL J MED, V357, P1239, DOI 10.1056/NEJMcpc079023
16. Silva-Moraes V, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760180478
17. Tustumi F, 2016, CLINICS, V71, P733, DOI 10.6061/clinics/2016(12)10